Sevelamer hydrochloride versus calcium salts as phosphate binder in chronic kidney disease: A systematic review

被引：0
|
作者：
Navaneethan, SD
Chaukiyal, P
Craig, J
Strippoli, GFM
机构：
[1] Unity Hlth Syst, Rochester, NY USA
[2] Cochrane Renal Grp, Sydney, NSW, Australia
来源：
AMERICAN JOURNAL OF KIDNEY DISEASES | 2006年 / 47卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
115
引用
收藏
页码：A47 / A47
页数：1
相关论文
共 50 条
  • [11] Different Effect of Lanthanum Carbonate and Sevelamer Hydrochloride on Calcium Balance in Patients with Moderate to Advanced Chronic Kidney Disease
    Makowka, Agnieszka
    Nowicki, Michal
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2021, 17 : 1145 - 1151
  • [12] Sevelamer versus calcium-based phosphate binders in chronic kidney disease: what should we conclude from the evidence to date?
    Johnson, David W.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2009, 24 (10) : 2970 - 2972
  • [13] Pleiotropic effects of the non-calcium phosphate binder sevelamer
    Nikolov, I. G.
    Joki, N.
    Maizel, J.
    Lacour, B.
    Drueke, T. B.
    Massy, Z. A.
    KIDNEY INTERNATIONAL, 2006, 70 : S16 - S23
  • [14] Sevelamer hydrochloride, a calcium-free phosphate binder, inhibits parathyroid cell proliferation in partially nephrectomized rats
    Nagano, N
    Miyata, S
    Obana, S
    Kobayashi, N
    Abe, M
    Fukushima, N
    Wada, M
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2003, 18 : 81 - 85
  • [15] Sevelamer hydrochloride, a phosphate binder, protects against deterioration of renal function in rats with progressive chronic renal insufficiency
    Nagano, N
    Miyata, S
    Obana, S
    Kobayashi, N
    Fukushima, N
    Burke, SK
    Wada, M
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2003, 18 (10) : 2014 - 2023
  • [16] Sevelamer Carbonate: A Review in Hyperphosphataemia in Adults with Chronic Kidney Disease
    Perry, Caroline M.
    Plosker, Greg L.
    DRUGS, 2014, 74 (07) : 771 - 792
  • [17] Sevelamer Carbonate: A Review in Hyperphosphataemia in Adults with Chronic Kidney Disease
    Caroline M. Perry
    Greg L. Plosker
    Drugs, 2014, 74 : 771 - 792
  • [18] A randomized, crossover design study of sevelamer carbonate powder and sevelamer hydrochloride tablets in chronic kidney disease patients on haemodialysis
    Fan, Stanley
    Ross, Calum
    Mitra, Sandip
    Kalra, Philip
    Heaton, Jeremy
    Hunter, John
    Plone, Melissa
    Pritchard, Nick
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2009, 24 (12) : 3794 - 3799
  • [19] Effects of sevelamer carbonate versus calcium acetate on vascular calcification, inflammation, and endothelial dysfunction in chronic kidney disease
    Mason, Darius
    Godugu, Kavitha
    Nnani, Daryl
    Mousa, Shaker A.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2022, 15 (02): : 353 - 360
  • [20] Phosphate binders in chronic kidney disease: a systematic review of recent data
    Jürgen Floege
    Journal of Nephrology, 2016, 29 : 329 - 340
12345